These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37012261)

  • 1. Shorter leukocyte telomere length protects against NAFLD progression in children.
    Wojcicki JM; Gill RM; Wilson L; Lin J; Rosenthal P
    Sci Rep; 2023 Apr; 13(1):5446. PubMed ID: 37012261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease.
    Kleiner DE; Brunt EM; Wilson LA; Behling C; Guy C; Contos M; Cummings O; Yeh M; Gill R; Chalasani N; Neuschwander-Tetri BA; Diehl AM; Dasarathy S; Terrault N; Kowdley K; Loomba R; Belt P; Tonascia J; Lavine JE; Sanyal AJ;
    JAMA Netw Open; 2019 Oct; 2(10):e1912565. PubMed ID: 31584681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of leukocyte telomere length with non-alcoholic fatty liver disease in patients with type 2 diabetes.
    Zhang M; Hu ML; Huang JJ; Xia SS; Yang Y; Dong K
    Chin Med J (Engl); 2019 Dec; 132(24):2927-2933. PubMed ID: 31809318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease and its prognosis associates with shorter leucocyte telomeres in a 21-year follow-up study.
    Korkiakoski A; Käräjämäki AJ; Ronkainen J; Auvinen J; Hannuksela J; Kesäniemi YA; Ukkola O
    Scand J Clin Lab Invest; 2022 May; 82(3):173-180. PubMed ID: 35416741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network.
    Brunt EM; Kleiner DE; Wilson LA; Unalp A; Behling CE; Lavine JE; Neuschwander-Tetri BA;
    Hepatology; 2009 Mar; 49(3):809-20. PubMed ID: 19142989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.
    Rastogi A; Shasthry SM; Agarwal A; Bihari C; Jain P; Jindal A; Sarin S
    APMIS; 2017 Nov; 125(11):962-973. PubMed ID: 29076589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of leukocyte telomere length with obesity-related traits in Asian children with early-onset obesity.
    Ooi DSQ; Dorajoo R; Gurung RL; Dehghan R; Lim YY; Ho CWL; Tay V; Karuppiah V; Loke KY; Lim SC; Liu JJ; Sng AA; Lee YS
    Pediatr Obes; 2021 Aug; 16(8):e12771. PubMed ID: 33501739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease.
    Nascimbeni F; Bedossa P; Fedchuk L; Pais R; Charlotte F; Lebray P; Poynard T; Ratziu V;
    J Hepatol; 2020 May; 72(5):828-838. PubMed ID: 31862486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvements in Histologic Features and Diagnosis Associated With Improvement in Fibrosis in Nonalcoholic Steatohepatitis: Results From the Nonalcoholic Steatohepatitis Clinical Research Network Treatment Trials.
    Brunt EM; Kleiner DE; Wilson LA; Sanyal AJ; Neuschwander-Tetri BA;
    Hepatology; 2019 Aug; 70(2):522-531. PubMed ID: 30549292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between telomere length and hepatic fibrosis in non-alcoholic fatty liver disease.
    Shin HK; Park JH; Yu JH; Jin YJ; Suh YJ; Lee JW; Kim W;
    Sci Rep; 2021 Sep; 11(1):18004. PubMed ID: 34504179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Fukusato T
    World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and clinical significance of portal inflammation, portal plasma cells, interface hepatitis and biliary injury in liver biopsies from patients with non-alcoholic steatohepatitis.
    Dhingra S; Mahadik JD; Tarabishy Y; May SB; Vierling JM
    Pathology; 2022 Oct; 54(6):686-693. PubMed ID: 35525796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Less Than Ideal Cardiovascular Health Is Associated With Shorter Leukocyte Telomere Length: The National Health and Nutrition Examination Surveys, 1999-2002.
    Gebreab SY; Manna ZG; Khan RJ; Riestra P; Xu R; Davis SK
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28154163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood obesity is associated with shorter leukocyte telomere length.
    Buxton JL; Walters RG; Visvikis-Siest S; Meyre D; Froguel P; Blakemore AI
    J Clin Endocrinol Metab; 2011 May; 96(5):1500-5. PubMed ID: 21349907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver histology and diffusion-weighted MRI in children with nonalcoholic fatty liver disease: A MAGNET study.
    Manning P; Murphy P; Wang K; Hooker J; Wolfson T; Middleton MS; Newton KP; Behling C; Awai HI; Durelle J; Paiz MN; Angeles JE; De La Pena D; McCutchan JA; Schwimmer JB; Sirlin CB
    J Magn Reson Imaging; 2017 Oct; 46(4):1149-1158. PubMed ID: 28225568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis.
    Harrison SA; Goodman Z; Jabbar A; Vemulapalli R; Younes ZH; Freilich B; Sheikh MY; Schattenberg JM; Kayali Z; Zivony A; Sheikh A; Garcia-Samaniego J; Satapathy SK; Therapondos G; Mena E; Schuppan D; Robinson J; Chan JL; Hagerty DT; Sanyal AJ
    J Hepatol; 2020 May; 72(5):816-827. PubMed ID: 31887369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and molecular-genetic indicators of inflammation and apoptosis in liver cirrhosis as an outcome of the progression of non-alcoholic steatohepatitis.
    Kurbatova IV; Topchieva LV; Dudanova OP; Shipovskaya AA
    Ter Arkh; 2019 May; 91(4):21-27. PubMed ID: 31094472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-alpha mediates the negative association between telomere length and kidney dysfunction.
    Qi M; Yu J; Ping F; Xu L; Li W; Zhang H; Li Y
    Int J Med Sci; 2023; 20(12):1592-1599. PubMed ID: 37859695
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis.
    Pelusi S; Cespiati A; Rametta R; Pennisi G; Mannisto V; Rosso C; Baselli G; Dongiovanni P; Fracanzani AL; Badiali S; Maggioni M; Craxi A; Fargion S; Prati D; Nobili V; Bugianesi E; Romeo S; Pihlajamaki J; Petta S; Valenti L
    Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2310-2319.e6. PubMed ID: 30708111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.